Similar Articles
1621 Serum metabolome profiles characterized by patients with hepatocellular carcinoma associated with hepatitis B and C
1622 Immunohistochemistry panel segregates molecular types of hepatocellular carcinoma in Brazilian autopsy cases
1623 Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib
1624 Pancreatic cancer stem cell markers and exosomes - the incentive push
1625 Preliminary study on overproduction of reactive oxygen species by neutrophils in diabetes mellitus
1626 Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids
1627 Clinical analysis of patients with hepatocellular carcinoma recurrence after living-donor liver transplantation
1628 Natural regression of fibrosis in chronic hepatitis B
1629 Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma
1630 Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA